Gillan v. Commissioner
Opinion
MEMORANDUM FINDINGS OF FACT AND OPINION
KORNER,
| Additions to Tax - Section | |||||
| Year | Deficiency | 1 6651(a) | 6653(a) | 6653(a)(1) | 6654 |
| 1980 | $ 148,840 | $ 37,210 | $ 7,442 | $ -- | $ 9,482 |
| 1981 | 14,354 | 3,588 | - | 718 | 1,097 |
Respondent determined further that an addition to tax under section 6653(a)(2) applies for 1981 in the amount of 50 percent of the interest due on an underpayment of $ 14,354.
After concessions by petitioner, 2 the issues for decision are: (1) Whether petitioner was denied a fair trial; (2) whether petitioner received the unreported income determined by respondent; (3) whether respondent violated
*351 FINDINGS OF FACT
Some of the facts have been stipulated and are so found. The stipulation of facts and exhibits attached thereto are incorporated herein by this reference.
Petitioner resided in Kirkland, Washington, when he filed his petition herein. He failed to file Federal income tax returns for the years at issue.
During all of 1980, and through February 11, 1981, petitioner was a partner with another individual in an enterprise that manufactured and distributed lysergic acid diethylamide (LSD). He was arrested by agents of the Federal Drug Enforcement Administration on February 11, 1981, and pled guilty later that year to running a continuing criminal enterprise in violation of
Respondent determined that petitioner*352 had received the following amounts of unreported income from the enterprise:
| 1980 | 1981 | |
| Gross Sales | $ 1,443,200 | $ 182,600 |
| Less - Manufacturing Cost | 524,800 | 66,400 |
| - Distribution Exp. | 300,000 | 37,962 |
| Net Income | $ 618,400 | $ 78,238 |
| Petitioner's 50% share | $ 309,200 | $ 39,119 |
Respondent based his determination of the enterprise's gross sales on his determination of the following amounts of pill production:
| Pills Produced | ||
| Month | 1980 | 1981 |
| January | 500,000 | 500,000 |
| February | 500,000 | 166,000 |
| March | 500,000 | -- |
| April | 500,000 | -- |
| May | 500,000 | -- |
| June | 250,000 | -- |
| July | 250,000 | -- |
| August | 250,000 | -- |
| September | 500,000 | -- |
| October | 500,000 | -- |
| November | 500,000 | -- |
| December | 500,000 | -- |
| Total | 5,250,000 | 666,000 |
Respondent determined that the pills were packaged in containers of 4,000 which were then sold for $ 1,100 each. Respondent determined that each container of pills cost $ 400 to manufacture and that distribution expenses totaled $ 300,000 for 1980, which represented 20.79 percent of gross sales. Respondent applied that percentage to the gross sales for 1981 to determine*353 the distribution expenses for that year.
Petitioner was served notice on September 16, 1987, that this case was set for trial on February 16, 1988. When the case was called on that date, petitioner requested a continuance. This Court denied the request.
OPINION
Petitioner's initial argument is that he was denied a fair trial by this Court's refusal to grant a continuance, and due to this Court's failure to subpoena witnesses for him.
Petitioner was served notice on September 16, 1987, that this case was set for trial on February 16, 1988. The first paragraph of the pretrial order that accompanied the notice stressed that "Absent a strong showing of good cause,
Petitioner requested a continuance on February 16, 1988, when this case was called at the calendar call for a trial session beginning on that date. The basis for his request was that*354 he had failed to subpoena witnesses that he believed he needed to present his case. This Court denied the motion, emphasizing that petitioner had been notified in September of 1987 that this case was set for trial on February 16, 1988. We have reconsidered our denial of the motion, and conclude that it was proper.
As we emphasized at trial, petitioner had five months to prepare this for trial. The pretrial order warned him that motions for continuance would generally be denied unless made 30 days before February 16, 1988. Armed with that knowledge, petitioner should have taken immediate steps to prepare for trial so that if he encountered difficulties, he would have time to resolve them. We note that subpoenas can be issued well in advance of trial and that this is therefore a matter that petitioner could easily have taken care of earlier. See Rule 147. Petitioner nevertheless waited until after this case was called to request a continuance. We do not believe that this reflects a diligent effort on his part to properly prosecute this case.
Petitioner's argument that he was denied a fair trial due to this Court's failure to subpoena*355 witnesses for him appears to be based on the mistaken premise that he has a constitutional right to have this Court pay his witness fees. Such is not the case. Civil litigants such as petitioners before this Court enjoy no constitutional right to have the Federal government pay their litigation expenses. See
Although petitioner argues that respondent used grand jury material in violation of
Respondent determined that all of petitioner's unreported income came from his illegal enterprise. Soltis testified that he computed the enterprise's gross sales based on a statement given by one of the enterprise's employees on February 11, 1981, the night the employee was arrested, to agents of the Federal Drug Enforcement Administration. He testified further that he contacted petitioner in prison to determine the enterprise's manufacturing costs and distribution expenses. He explained that he based his determination of the enterprise's manufacturing costs and distribution expenses on petitioner's statements that manufacturing costs were approximately $ 400 per container of pills and that distribution expenses were approximately $ 300,000. Finally, Soltis stated that he attributed one-half of the enterprise's net income for 1980 and 1981 to petitioner. None of the*357 sources that Soltis identified compromises a grand jury proceeding. In these circumstances, we conclude that evidence does not support petitioner's claim that respondent used grand jury material in violation of
Petitioner argues that this Court erred in admitting exhibit 4-D. In admitting that exhibit over petitioner's objections, we specified that we were admitting it for the limited purpose of showing the basis for one of the alternative methods used by respondent in initially determining petitioner's unreported income. We noted that respondent had ultimately chosen to base the notice of deficiency on another method of determining petitioner's unreported income, and opined at the time that the exhibit therefore "has very limited probative value for anything." We have in fact not relied on the exhibit in reaching our decision herein. We accordingly need not address petitioner's argument that the exhibit was improperly admitted. See Rule 160;
The next issue for decision is whether*358 petitioner received the unreported income determined by respondent for the years at issue.
At the outset, we must address petitioner's argument that respondent bears the burden of proof on this issue. Petitioner cites to
As respondent points out on brief, the Ninth Circuit has made it clear that the rationale of
Petitioner's guilty plea to running a continuing criminal enterprise establishes his involvement in an illegal income-producing activity. One of the enterprise's employees testified that it produced an average of 500,000 LSD pills each month from January of 1980 through February 11, 1981, except for June and July of 1980 when the production was interrupted for a move. He testified further that the pills were packaged in containers of 4,000 which sold for $ 1,100, and stated that petitioner maintained a comfortable life style during the years at issue and dealt extensively in cash.
In sum, the evidence provides a rational basis to support respondent's determination that petitioner received unreported income from an illegal activity. We accordingly hold that petitioner bears the burden of going forward as well as the burden of proof in this case.
Soltis testified and explained the factors he used in determining the amount of petitioner's unreported income, such as the number of pills the enterprise produced, how they were packaged,*360 and the amount for which they were sold, and such factors were largely confirmed by the testimony of a witness who had worked for the enterprise.
The only conflict between respondent's determinations of petitioner's unreported income and the evidence introduced at trial relates to the number of pills produced during June, July, and August of 1980. The witness who had worked for the enterprise testified that no LSD pills were produced during June and July of 1980, and that an average of 500,000 pills a month were produced during the balance of 1980. Respondent determined that 250,000 pills a month were produced in June, July, and August of 1980, and that 500,000 pills were produced in each of the other months. We found the witness's testimony to be credible, and accordingly conclude that respondent's determinations of petitioner's unreported income should be adjusted as follows to reflect the production in 1980 of 250,000 4 fewer LSD pills than he determined:
| 1980 Income | |
| 5,000,000 pills / 4,000 pills/container = | 1,250 containers |
| Gross Sales: 1,240 containers x $1,100 = | $ 1,375,000 |
| Manufacturing Cost: 1,250 containers x $ 400 = | 500,000 |
| Distribution Expense (21.82%) | 300,000 |
| Net Income | $ 575,000 |
| Petitioner's One-Half Share | $ 287,500 |
The adjustment to 1980 increases the percentage of the enterprise's gross sales represented by its distribution expense. 5 The application of that increased percentage to 1981 results in an increase in the enterprise's distribution expense, and a decrease in petitioner's net income as determined by respondent, as follows:
| 1981 Income | |
| 666,000 pills / 4,000 pills/container = 166 containers | |
| Gross Sales: 166 containers x $ 1,100 = | $ 182,600 |
| Manufacturing Cost: 166 containers x $ 400 = | 66,400 |
| Distribution Expense: $ 182,600 x 21.82% = | 39,844 |
| Net Income | $ 76,356 |
| Petitioner's One-Half Share | $ 38,178 |
Petitioner's next argument is that he is entitled to a deduction for the value of assets that he derived from the manufacture and sale of LSD, and which he forfeited to the United States. We*362 disagree. The forfeiture of assets used in an illegal enterprise results in a loss deductible, if at all, under section 165 rather than an expense deductible under section 162.
The final issue for decision is whether petitioner is liable for the additions to tax for negligence determined by respondent. Petitioner bears the burden of proving that the additions, which were determined by respondent in his notice of deficiency, do not apply.
Negligence*363 under section 6653(a) is defined as lack of due care or failure to do what a reasonable and ordinarily prudent person would do under the circumstances.
We accordingly hold that petitioner has failed to prove that he is not liable for the additions to tax for negligence for both of the years at issue. We hold further that he has failed to prove that the entire underpayment for 1981 is not attributable to negligence for purposes*364 of the section 6653(a)(2) addition.
To reflect the foregoing,
Footnotes
1. All statutory references are to the Internal Revenue Code of 1954, as in effect in the years in issue, and all Rule references are to the Tax Court Rules of Practice and Procedure, except as otherwise noted. ↩
2. Petitioner failed to address on brief the additions determined by respondent under secs. 6651(a) and 6654. In these circumstances, we consider petitioner to have conceded the applicability of those additions. Rule 151(e);
affd. without published opinionStrasser v. Commissioner, T.C. Memo. 1986-579 n. 13838 F.2d 1203↩ (2d Cir. 1987) .3. See
, for a general discussion ofGreater Display & Wire Forming, Inc. v. Commissioner, T.C. Memo. 1988-231Fed. R. Crim. P. 6(e)↩ .4. This amount reflects production of 250,000 pills less than respondent determined for each of June and July, and production of 250,000 pills more than respondent determined for August. ↩
5. Petitioner presented no evidence concerning his manufacturing or distribution costs which would conflict with respondent's determination. ↩
Case-law data current through December 31, 2025. Source: CourtListener bulk data.